Acasti Pharma DPO Ratio 2011-2026 | ACST

Annual DPO Ratio Acasti Pharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	4.39 K	-	-	-	-	1.68 K	383	400	292	39.5 K	-

All numbers in USD currency

Maximum	Minimum	Average
39.5 K	292	7.77 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Enlivex Therapeutics Ltd. ENLV	193	$ 0.8	-4.39 %	$ 36.6 M	Israel
Exelixis EXEL	148	$ 45.87	-5.81 %	$ 12.5 B	USA
Fortress Biotech FBIO	400	$ 2.42	-5.1 %	$ 67.5 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
ACADIA Pharmaceuticals ACAD	75.2	$ 22.16	3.14 %	$ 3.67 B	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	7.93 K	$ 3.15	-	$ 655 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	133	$ 20.85	-13.74 %	$ 2.65 B	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.58	-7.06 %	$ 420 M	Britain
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Завод ДИОД DIOD	30.3	-	-	-	Russia
Фармсинтез LIFE	306	-	-	-	Russia